debrisoquin has been researched along with Colitis, Ulcerative in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladero, JM | 1 |
| Benítez, J | 1 |
| Serrano, M | 1 |
| García-Paredes, J | 1 |
| Diaz-Rubio, M | 1 |
1 other study available for debrisoquin and Colitis, Ulcerative
| Article | Year |
|---|---|
Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Debrisoquin; Female; Humans; Male; Oxidation-Reduction; P | 1995 |